Compounds > 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide
Page last updated: 2024-09-03

5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and Injury, Myocardial Reperfusion

5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide has been researched along with Injury, Myocardial Reperfusion in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, MF; Jiang, JL; Li, YJ; Li, YP; Xie, QY; Yang, TL1

Other Studies

1 other study(ies) available for 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and Injury, Myocardial Reperfusion

ArticleYear
The endothelin receptor antagonist decreases ischemia/reperfusion-induced tumor necrosis factor production in isolated rat hearts.
    International journal of cardiology, 2005, Apr-28, Volume: 100, Issue:3

    Topics: Animals; Antihypertensive Agents; Dansyl Compounds; Endothelin-1; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha

2005